Intrathecal Hydrocortisone in the Treatment of Tuberculous Meningitis (Preliminary Report)

Main Article Content

Harsoyo N.
Moeljono S. Trastotenojo
Soejono Soejono
Dedy Abubakar
Indra Warman

Abstract

A trial on the treatment of tuberculous meningitis with intrathecal hydrocortisone, beside INH, PAS, and Streptomycin, performed at the Dr. Kariadi General Hospital in October 1972, is reported. Eighteen patients were treated, giving good results; 5.6% mortality were noted. A great number of complications


of optic nerve atrophy (61.1 %) were found and 22.2% with early atrophy recovered. The results are better compared with those of Choremis et al. (1957) who found a mortality of 13.7% among 29 patients with tuberculous meningitis treated in the same way, except P.A.S.

Article Details

How to Cite
1.
N. H, Trastotenojo M, Soejono S, Abubakar D, Warman I. Intrathecal Hydrocortisone in the Treatment of Tuberculous Meningitis (Preliminary Report). PI [Internet]. 17Sep.2019 [cited 31Mar.2020];16(9-10):355-0. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2310
Section
Infection & Tropical Pediatrics
Received 2019-09-17
Published 2019-09-17